HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses

Published:2013-02 Issue:2 Volume:4 Page:e519-e519
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Bolden J E,Shi W,Jankowski K,Kan C-Y,Cluse L,Martin B P,MacKenzie K L,Smyth G K,Johnstone R W

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis20139.pdf

Reference54 articles.

1. Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY et al. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005; 113: 264–268.

2. Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ et al. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 2001; 92: 1300–1304.

3. Krusche CA, Wulfing P, Kersting C, Vloet A, Bocker W, Kiesel L et al. Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res Treat 2005; 90: 15–23.

4. Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y et al. HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res 2004; 10: 6962–6968.

5. Halkidou K, Gaughan L, Cook S, Leung HY, Neal DE, Robson CN . Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 2004; 59: 177–189.

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer;Journal of Medicinal Chemistry;2024-08-07

2. Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma;2024-07-02

3. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules;Cancer Letters;2024-06

4. HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes;Nature Communications;2024-05-24

5. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy;Cancer Cell International;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3